0001209191-20-054372.txt : 20201008
0001209191-20-054372.hdr.sgml : 20201008
20201008210304
ACCESSION NUMBER: 0001209191-20-054372
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201008
FILED AS OF DATE: 20201008
DATE AS OF CHANGE: 20201008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gharib Samir M.
CENTRAL INDEX KEY: 0001533302
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39594
FILM NUMBER: 201231926
MAIL ADDRESS:
STREET 1: 2655 PINE STREET
STREET 2: #6
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001683553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812154263
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 294-1687
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-10-08
0
0001683553
SPRUCE BIOSCIENCES, INC.
SPRB
0001533302
Gharib Samir M.
2001 JUNIPERO SERRA BOULEVARD, SUITE 640
DALY CITY
CA
94014
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
1.64
2030-06-07
Common Stock
118483
D
Stock Option (Right to Buy)
3.07
2030-08-06
Common Stock
71548
D
The shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase, and vest over a four-year period commencing May 1, 2020, with 1/4th of the shares vesting on May 1, 2021 and 1/36th of the remaining shares vesting on a monthly basis.
The shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase, and vest over a four-year period commencing August 7,2020, with 1/48th of the shares vesting on a monthly basis.
/s/ Samir Gharib
2020-10-08